REGISTERED NUMBER: 09231427 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

EX PHARMACEUTICAL INSPECTORS CONSORTIUM

LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mrs E A Allanson

D P Jones

REGISTERED OFFICE:

101 Galgate

Barnard Castle

Co. Durham

DL12 8ES

REGISTERED NUMBER:

09231427 (England and Wales)

ACCOUNTANTS:

Blaeford Gordon & Company Ltd

101 Galgate

Barnard Castle

Co. Durham

DL12 8ES

FIXED ASSETS

Tangible assets

4

34,040

42,810

CURRENT ASSETS

Debtors

5

399,333

291,046

Cash at bank

556,847

294,648

956,180

585,694

CREDITORS

Amounts falling due within one year

6

236,738

159,550

NET CURRENT ASSETS

719,442

426,144

TOTAL ASSETS LESS CURRENT LIABILITIES

753,482

468,954

CREDITORS

Amounts falling due after more than one year

7

-

(3,267

)

PROVISIONS FOR LIABILITIES

(8,510

)

(10,702

)

NET ASSETS

744,972

454,985

CAPITAL AND RESERVES

Called up share capital

900

900

Retained earnings

744,072

454,085

SHAREHOLDERS' FUNDS

744,972

454,985

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 January 2026 and were signed on its behalf by:

Mrs E A Allanson - Director

D P Jones - Director

1.	STATUTORY INFORMATION

Ex Pharmaceutical Inspectors Consortium Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Fixtures and fittings

-

25% on reducing balance

Motor vehicles

-

20% on reducing balance

Computer equipment

-

25% on reducing balance

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2024 - 8 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

£

£

£

COST

At 1 December 2024

and 30 November 2025

1,980

60,375

9,276

71,631

DEPRECIATION

At 1 December 2024

1,832

21,735

5,254

28,821

Charge for year

37

7,728

1,005

8,770

At 30 November 2025

1,869

29,463

6,259

37,591

NET BOOK VALUE

At 30 November 2025

111

30,912

3,017

34,040

At 30 November 2024

148

38,640

4,022

42,810

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Motor

vehicles

£

COST

At 1 December 2024

and 30 November 2025

60,375

DEPRECIATION

At 1 December 2024

21,735

Charge for year

7,728

At 30 November 2025

29,463

NET BOOK VALUE

At 30 November 2025

30,912

At 30 November 2024

38,640

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade debtors

399,333

275,603

VAT

-

15,443

399,333

291,046

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Hire purchase contracts

3,243

9,925

Trade creditors

14,075

8,286

Tax

130,188

107,487

Social security and other taxes

20,963

-

VAT

25,954

-

Accrued expenses

42,315

33,852

236,738

159,550

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30.11.25

30.11.24

£

£

Hire purchase contracts

-

3,267

8.	ULTIMATE CONTROLLING PARTY

The controlling party is not known.